Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
Clinical trial NCT05024721 · COMPLETED
Trial details
- NCT number
- NCT05024721
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-09
- Primary completion
- 2022-03-07
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.